Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study
一项回顾性研究：70岁及以上慢性淋巴细胞白血病患者接受苯达莫司汀联合或不联合利妥昔单抗治疗的人口统计学特征、治疗模式、安全性和真实世界疗效
期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/2040620713478629
Kolibaba, Kathryn S; Sterchele, James A; Joshi, Avani D; Forsyth, Michael; Alwon, Erin; Beygi, Hooman; Kennealey, Gerard T
